A woman performing a breast self-examination. A domestic research team has developed a predictive score to determine the need for additional axillary lymph node surgery in breast cancer patients. Getty Images Bank
A predictive score has been developed to help breast cancer patients avoid extensive axillary lymph node dissection while not missing necessary opportunities for anticancer treatment. Using five indicators, including tumor size and lymph node metastasis, it predicts the risk of additional lymph node metastasis that is not detected in initial examinations.
On 4 November, a surgical team led by Professor Kwan Ho Lee at Kangbuk Samsung Hospital announced that it had developed a score to predict occult high-risk lymph node metastasis by analyzing clinical and pathological data from patients with hormone receptor–positive, HER2-negative breast cancer.
In breast cancer surgery, a sentinel lymph node biopsy is performed to check whether the cancer has spread to the axillary lymph nodes by removing only a small number of nodes. It is a method of examining the lymph nodes that are most likely to be the first site of metastasis.
By contrast, axillary lymph node dissection, which involves extensive removal of axillary lymph nodes, can cause complications such as lymphedema of the arm, sensory disturbances, and restricted shoulder movement, and its use is therefore being reduced.
The American Society of Clinical Oncology (ASCO) also recommends that, in some early breast cancer patients, even when cancer is found in the sentinel lymph nodes, additional axillary lymph node dissection may be omitted if certain conditions are met. However, the decision to perform surgery depends on the extent of cancer progression and radiotherapy plans.
The challenge is that omitting additional surgery may prevent accurate assessment of the true extent of lymph node metastasis. In some patients, only 1–3 metastatic nodes are found in the sentinel lymph nodes, but when other lymph nodes are examined, the actual number of metastatic nodes is four or more.
When the extent of metastasis is underestimated in this way, it can affect postoperative treatment decisions. In particular, in hormone receptor–positive, HER2-negative breast cancer, the use of the targeted therapy abemaciclib, which reduces the risk of recurrence, may depend on the number of lymph node metastases and tumor characteristics.
In other words, the core of this study is not to reduce axillary surgery unconditionally, but to find a balance between avoiding the burden of additional surgery and accurately identifying patients who require treatment.
● Analysis of 160 breast cancer patients… Occult lymph node metastasis found in 17.5%The research team analyzed 160 patients with hormone receptor–positive, HER2-negative breast cancer who underwent surgery at Kangbuk Samsung Hospital between 2015 and 2022 and were found to have 1–3 sentinel lymph node metastases.
These patients underwent additional axillary lymph node dissection after sentinel lymph node biopsy. Analysis showed that 28 patients, or 17.5% of the total, actually had four or more metastatic lymph nodes.
Preoperative imaging tests—ultrasound, magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET-CT), and computed tomography (CT)—were not able to significantly predict these occult high-risk metastases.
In response, the research team selected five factors: ▲ two or more metastatic sentinel lymph nodes ▲ lymphovascular invasion ▲ tumor size of at least 2 cm ▲ Ki-67 index of 20% or higher, indicating the degree of cancer cell proliferation ▲ multifocal tumors.
If a patient met a given criterion, 1 point was assigned, and risk was assessed on a scale from 0 to 5 points.
Analysis showed that the low-risk group with a score of 0–1 consisted of 51 patients, approximately 32% of the total. Among them, only 2 patients had four or more metastatic lymph nodes, corresponding to 3.9%. The negative predictive value indicating the probability of no high-risk lymph node metastasis in the low-risk group was 96.1%.
Notably, among 43 low-risk patients who did not meet the existing criteria for abemaciclib treatment, no occult high-risk lymph node metastasis was identified.
Through statistical decision analysis, the research team estimated that using this score could reduce approximately 14 unnecessary axillary lymph node dissections per 100 patients.
Professor Kwan Ho Lee, Department of Surgery, Kangbuk Samsung Hospital
● Suggests the possibility of omitting surgery, but further validation is neededProfessor Lee stated, “Among patients who underwent only sentinel lymph node biopsy, there were no cases of lymphedema. If axillary dissection can be avoided, patients’ quality of life changes significantly,” adding, “This study proposes an approach that considers both the possibility of omitting axillary lymph node dissection to reduce postoperative complications such as lymphedema and the need to secure appropriate adjuvant treatment opportunities through accurate staging.”
However, this study analyzed records of 160 patients who underwent surgery in the past at a single hospital. It has not yet been confirmed whether reducing surgery by applying the newly developed score in real-world practice would have no adverse impact on cancer recurrence or survival. In addition, 2 of the 51 patients assessed as having a low risk of additional metastasis actually had four or more metastatic lymph nodes. Therefore, not all patients can avoid additional surgery, even if they have a low score.
Professor Lee said, “It is expected to help more accurately assess each patient’s risk, reducing unnecessary surgical burden while not missing necessary treatments,” and emphasized, “To apply this in clinical practice, external validation through multicenter studies involving more patients is needed.”
The study findings were published in the official journal of the Society of Surgical Oncology, Annals of Surgical Oncology.
Reference paperhttps://pubmed.ncbi.nlm.nih.gov/42298079/
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.
Popular News